Announcement of the new chairperson of The Company
Date of events
2022/05/27
To which item it meets
paragraph 6
Statement
1.Date of the board of directors resolution or date of occurrence of the
change:2022/05/27
2.Position (Please enter chairperson or president/general manager):
Chairperson
3.Name of the previous position holder:Ted Tu
4.Resume of the previous position holder:Chairperson, PharmaEngine, Inc
5.Name of the new position holder:Ted Tu
6.Resume of the new position holder:Chairperson, PharmaEngine, Inc
7.Circumstances of change (Please enter "resignation", "dismissal",
"term expired" , "job relocation", "severance", "retirement",
"death" or "new appointment"):term expired
8.Reason for the change:term expired
9.Effective date of the new appointment:2022/05/27~2025/05/26
10.Any other matters that need to be specified:None
Attachments
Original Link
Original Document
Permalink
Disclaimer
PharmaEngine Inc. published this content on 27 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 May 2022 10:41:57 UTC.
PharmaEngine, Inc. is a Taiwan-based company principally engaged in the development of new drugs, as well as the licensing and sales of products. The Company is developing three new anti-cancer drugs under the brand of ONIVYDE, which are nal-IRI, MM-398 and PEP02. The Company distributes its products mainly to overseas markets,
PHARMAENGINE, INC. 
